In order to comprehensively assess the potential diagnostic utility of FABP1 expression in cancer, a preexisting set of tissue microarrays containing more than 17,000 tumor tissue samples from 150 different tumor types and subtypes as well as 76 non-neoplastic tissue categories was analyzed by immunohistochemistry (IHC) in this study. The gene discussed is FABP1; the disease is cancer.